从小类药品到口服活性皮佩拉-2,5-基环类药物的进步
Vladislav Deigin1, Natalia Linkova2, Olga Volpina1
1The Laboratory of Synthetic Vaccines of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya St., 16/10, Moscow 117997, Russia.
International journal of molecular sciences
|September 9, 2023
概括
开发口服可用的类药物是一项挑战. 使用分支皮佩拉-2,5-二的新平台创建了稳定的peptidomimetics与保存的生物活性,用于口服.
科学领域:
- 药用化学 医学化学
- 药物运输 药物运输 药物运输
- 酸科学 酸科学
背景情况:
- 口服类药物仍然是药物开发中的一个重大障碍.
- 现有的方法往往在稳定性和生物可用性方面扎.
- 基于的药物具有治疗潜力,但在配方方面面临着挑战.
研究的目的:
- 引入一种新的化学平台,用于制造口服可用的类模拟剂.
- 为了证明小,活性的转化为口服稳定的化合物.
- 探索开发用于口服的短类药物.
主要方法:
- 一个化学平台的设计,基于分支的皮佩拉-2,5-.
- 片或生物活性分子通过链接器对生物载体进行共价附着.
- 制备具有特定生物活性的类仿制药.
主要成果:
- 成功创建了一种口服可用的皮多米米特平台.
- 在口服的化合物中证明了生物活性的保存.
- 合成的模仿药物表现出血红刺激,血红抑制和辅助活性.
- 观察到对等分子中的互惠生物活性.
结论:
- 开发的平台可以通过口服提供基于的治疗方法.
- 这种方法有助于活性转化为口服稳定的药物.
- 这项研究突出了类药物开发的进化路径,指向口服环和类模拟剂.
相关概念视频
Prodrugs
2.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.7K
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K


